Literature DB >> 702065

The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions.

T H Stanton, C E Calkins, J Jandinski, D J Schendel, O Stutman, H Cantor, E A Boyse.   

Abstract

The antiserum (B6 X A-Tlab) anti-A (Tlaa) defines several TL antigens expressed exclusively on thymocytes. When reacted with peripheral lymphocytes, the same antiserum defines another antigenic system, provisionally termed Qa-1. The genotypic disparity distinguishing the recipients and donors in this immunization comprises a section of chromosome 17 extending from a crossover point between H-2D and Tla to a presently unmarked point beyond Tla. Therefore although Qa-1 may constitute a single cell surface component, it is equally probable that the Qa-1 system defines two or more cell surface components determined by genes in this region, each of which may be expressed on a different cell set. Cytotoxicity assays indicate that Qa-1 antigen is expressed on Lyt-1 cells and Lyt-123 cells, and may serve to subclassify these two cell sets; it is not known whether Qa-1+ cells may occur within the small Lyt-23 set. There may be also be a cell set with the phenotype Thy-1--:Qa-1+. Another distinctive feature of the Qa-1 system is the characteristic profile of responses to mitogens exhibited by spleen cell populations from which Qa-1+ cells have been eliminated; in conventional assay of [3H]thymidine incorporation the response to lipopolysaccharide was essentially unchanged, the response to phytohemagglutinin M (PHA-M) was virtually abolished, and the response to concanavalin A (Con A) was reduced by 40%. The third distinctive feature of the Qa-1 system is the characteristic profile of changes which elimination of Qa-1+ cells produces in tests of immune function in vitro: (a) proliferation, measured by [3H]thymidine incorporation, in mixed lymphocyte culture (MLC) with major histocompatibility complex (MHC)-incompatible stimulator cells, was not affected. (b) in tests of cell-mediated cytotoxicity (CMC) of MHC-incompatible target cells, neither the generation nor the effector functions of cytotoxic lymphocytes was affected, implying that Lyt-23 prekiller and killer cells are Qa-1--. (c) primary and secondary responses to SRBC were considerably augmented, suggesting that Qa-1+ cells may be responsible for suppression in this test system. (d) accordingly the suppression of the anti-sheep erythrocyte (SRBC) response normally engendered in spleen cells by culture with SRBC was profoundly reduced by elimination of Qa-1+ cells, either before or after culture. (e) the suppression of the anti-SRBC response normally engendered in spleen cells cultured with Con A was reduced by removal of Qa-1+ cells before but not after culture with Con A. Although analysis is as yet far from complete, the Qa-1 system should already be of considerable value because it distinguishes a population of lymphocytes that is not defined by any other antigenic system, according to three criteria: (a) representation of Qa-1 cells among T-cell sets defined by Lyt phenotypes, (b) the profile of responses to mitogens exhibited by lymphocyte populations depleted of Qa-1+ cells, and (c) the profile of immune responses of lymphocyte populations depleted of Qa-1+ cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702065      PMCID: PMC2185028          DOI: 10.1084/jem.148.4.963

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Regulation of cellular and humoral immune responses by T-cell subclasses.

Authors:  H Cantor; E A Boyse
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

2.  Separation of helper and suppressor T lymphocytes. II. Ly phenotypes and lack of DNA synthesis requirement for the generation of concanavalin A helper and suppressor cells.

Authors:  H Y Tse; R W Dutton
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

3.  Ly antigens: markers of T cell function on mouse spleen cells.

Authors:  J A Hirst; P C Beverley; P Kisielow; M K Hoffmann; H F Oettgen
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

4.  Induction of specific suppressor T cells in vitro.

Authors:  D D Eardley; R K Gershon
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

5.  Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

6.  Immunoregulatory circuits among T-cell sets. Identification of a subpopulation of T-helper cells that induces feedback inhibition.

Authors:  H Cantor; J Hugenberger; L McVay-Boudreau; D D Eardley; J Kemp; F W Shen; R K Gershon
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

7.  Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes.

Authors:  R R Rich; C W Pierce
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

8.  Separation of helper T cells from suppressor T cells expressing different Ly components. I. Polyclonal activation: suppressor and helper activities are inherent properties of distinct T-cell subclasses.

Authors:  J Jandinski; H Cantor; T Tadakuma; D L Peavy; C W Pierce
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

9.  Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition.

Authors:  D D Eardley; J Hugenberger; L McVay-Boudreau; F W Shen; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

  10 in total
  14 in total

Review 1.  An integrated view of suppressor T cell subsets in immunoregulation.

Authors:  Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  A non-T:non-B cell bears I-A, I-E, I-J, and Tla (Qa-1?) determinants.

Authors:  S Habu; K Yamauchi; R K Gershon; D B Murphy
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

3.  Surface mapping of mouse thymocytes.

Authors:  L Flaherty; D Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

Review 4.  Surface receptors on lymphoreticular cells: sensory devices for host recognition of foreign antigens and neoplasia.

Authors:  B E Elliott; R S Kerbel; Z A Nagy
Journal:  Can Med Assoc J       Date:  1980-06-21       Impact factor: 8.262

5.  Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.

Authors:  Vily Panoutsakopoulou; Katharina M Huster; Nami McCarty; Evan Feinberg; Rijian Wang; Kai W Wucherpfennig; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 6.  Natural and induced immunity to mouse mammary tumors and the mammary tumor virus (MuMTV).

Authors:  O Stutman
Journal:  Springer Semin Immunopathol       Date:  1982

7.  Structure and expression of glycoproteins controlled by the Qa-1a allele.

Authors:  E Rothenberg; D Triglia
Journal:  Immunogenetics       Date:  1981-12       Impact factor: 2.846

8.  Expression of differentiation and murine leukemia virus antigens on cells of primary tumors and cell lines derived from chemically induced lymphomas of RF/J mice.

Authors:  M M Goodenow; F Lilly
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  New complexities at the Qa-1 locus.

Authors:  L Flaherty; E Rinchik; K DiBiase
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis.

Authors:  C Morimoto; E L Reinherz; Y Borel; E Mantzouranis; A D Steinberg; S F Schlossman
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.